Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

July 11, 2018

Artificial Ovary Might Help Women Conceive After Ovarian Cancer Treatment, Study Reports

News

Researchers have developed a new technique for growing human ovarian follicles — the small fluid-filled sacs that give rise to mature eggs — on a bioengineered ovarian scaffold made of ... Read more

July 2, 2018July 2, 2018

Anti-cancer Protein, Once Reactivated, Seen to Target Ovarian Cancer Cells in Early Study

News

Researchers have discovered how reactivating a protein called OPCML — a tumor suppressor molecule usually reduced or lost in cancer patients — works to suppress ovarian cancer cells. These findings ... Read more

May 25, 2018May 25, 2018

Mirvetuximab Soravtansine Combo Therapies Show Promise for Ovarian Cancer, Clinical Trial Shows

News

Combinations of mirvetuximab soravtansine (IMGN853) with either Avastin (bevacizumab) or Paraplatin (carboplatin) are showing promise in certain ovarian cancer patients, particularly those who received multiple prior lines of therapy, the investigational therapy’s developer, ImmunoGen, recently announced. ... Read more

May 14, 2018

Researchers Discover Mutations Behind Resistance to PARP Inhibitors Like Lynparza

News

Scientists have found mutations in the poly ADP-ribose polymerase (PARP) gene that cause resistance to PARP inhibitor therapies — such as Lynparza (olaparib) — in a mouse model and in one ... Read more

April 16, 2018

Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds

News

A class of inhibitors approved for the treatment of several blood cancers may be an effective therapy for ovarian cancer patients who have mutations in the ARID1A gene, according to researchers. ... Read more

March 2, 2018March 2, 2018

Scientists Discover Gene Variant that Could Help Predict Chemo Outcomes

News

Researchers have discovered new gene variants that affect how ovarian cancer patients respond to standard chemotherapy treatments Paraplatin (carboplatin) and Taxol (paclitaxel). The variants influence how a patient processes chemotherapy medications. ... Read more

February 28, 2018February 28, 2018

Potential Therapeutic Target Identified to Fight Metastasis in Ovarian Cancer

News

High levels of CXCR4, a receptor for signaling molecules that drive cell movement, allow ovarian cancer cells to grow faster and spread to other parts of the body, a study ... Read more

December 15, 2017

Mouse Study Reveals Potential Combination Therapy for Ovarian Cancer

News

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered a combination therapy that may hold promise in halting ovarian cancer progression. The combination of epigenetic therapy and immunotherapy reduced ... Read more